University Hospital "Sestre Milosrdnice"
Also known as: Department for Medical Oncology; University Hospital/Inselspital | Department of Gynecology and Obstetrics, University Hospital Center Sestre milosrdnice, Zagreb, Croatia | Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Center Sestre milosrdnice | Dept Respiratory Medicine, University Hospital, Umeå | Hvidovre Hospital, University hospital, Cardio-pulmonary depart. | University Hospital | University Hospital "Sestre Milosrdnice" | University Hospital Sestre Milosrdnice
Highest phase reached
Phase 4
First clinical trial
Feb 28, 2005Last known activity
Jul 31, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (13 distinct, 10 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
Recent trials (18)
- NCT06489925Sponsor investigatorEarly Phase 1Jul 31, 2024
- NCT06489925Lead sponsorEarly Phase 1Jul 31, 2024
- NCT05840406Reponsible party - principal investigatorN/AApr 1, 2024
- NCT05840406Overall official - principal investigatorN/AApr 1, 2024
- NCT05840406Lead sponsorN/AApr 1, 2024
- NCT06243536Sponsor investigatorPhase 4Feb 1, 2024
- NCT06243536Lead sponsorPhase 4Feb 1, 2024
- NCT05781243CollaboratorPhase 4Jun 19, 2023
- NCT05636787OfficialPhase 2Mar 31, 2023
- NCT05659810Overall official - principal investigatorEarly Phase 1Oct 30, 2021
- NCT04160611Study chairPhase 3Sep 1, 2019
- NCT04160611Lead sponsorPhase 3Sep 1, 2019
- NCT04160611Reponsible party - principal investigatorPhase 3Sep 1, 2019
- NCT03534869Reponsible party - principal investigatorPhase 3Nov 1, 2016
- NCT03534869Lead sponsorPhase 3Nov 1, 2016
Details
- Last known activity
- Jul 31, 2024